Simandi Zoltan, Horvath Attila, Nagy Peter, Nagy Laszlo
Sanford-Burnham-Prebys Medical Discovery Institute at Lake Nona.
Department of Biochemistry and Molecular Biology, Research Center for Molecular Medicine, Medical and Health Science Center, University of Debrecen.
J Vis Exp. 2016 Jun 21(112):53978. doi: 10.3791/53978.
Embryonic development is a multistep process involving activation and repression of many genes. Enhancer elements in the genome are known to contribute to tissue and cell-type specific regulation of gene expression during the cellular differentiation. Thus, their identification and further investigation is important in order to understand how cell fate is determined. Integration of gene expression data (e.g., microarray or RNA-seq) and results of chromatin immunoprecipitation (ChIP)-based genome-wide studies (ChIP-seq) allows large-scale identification of these regulatory regions. However, functional validation of cell-type specific enhancers requires further in vitro and in vivo experimental procedures. Here we describe how active enhancers can be identified and validated experimentally. This protocol provides a step-by-step workflow that includes: 1) identification of regulatory regions by ChIP-seq data analysis, 2) cloning and experimental validation of putative regulatory potential of the identified genomic sequences in a reporter assay, and 3) determination of enhancer activity in vivo by measuring enhancer RNA transcript level. The presented protocol is detailed enough to help anyone to set up this workflow in the lab. Importantly, the protocol can be easily adapted to and used in any cellular model system.
胚胎发育是一个涉及许多基因激活和抑制的多步骤过程。已知基因组中的增强子元件在细胞分化过程中有助于基因表达的组织和细胞类型特异性调控。因此,对其进行鉴定和进一步研究对于理解细胞命运的决定方式非常重要。整合基因表达数据(如微阵列或RNA测序)和基于染色质免疫沉淀(ChIP)的全基因组研究结果(ChIP测序)能够大规模鉴定这些调控区域。然而,细胞类型特异性增强子的功能验证需要进一步的体外和体内实验步骤。在这里,我们描述了如何通过实验鉴定和验证活性增强子。本方案提供了一个逐步的工作流程,包括:1)通过ChIP测序数据分析鉴定调控区域,2)在报告基因检测中克隆并实验验证所鉴定基因组序列的假定调控潜力,3)通过测量增强子RNA转录水平在体内确定增强子活性。所提供的方案足够详细,有助于任何人在实验室中建立此工作流程。重要的是,该方案可以很容易地适用于任何细胞模型系统并在其中使用。